论文部分内容阅读
血管紧张素Ⅱ受体拮抗剂(AⅡA)是二十世纪九十年代中期开始应用于临床的新一类的治疗高血压并同时可能治疗如心衰、左室肥厚、陈旧性心梗及肾功能损害等疾病的药物。本文就近年来有关的临床研究进展情况作一概述。1 AⅡA分类1.1 单纯的AⅡA 为口服非肽类药物,包括氯沙坦(losartan)、缬沙坦(valsartan)、坎地沙坦(can-
Angiotensin II Receptor Antagonists (AIIA) are a new class of clinical therapies for the treatment of hypertension beginning in the mid-1990s and may also treat conditions such as heart failure, left ventricular hypertrophy, old myocardial infarction, and renal function Damage and other diseases of the drug. This article gives an overview of the progress of clinical research in recent years. 1 AIIA Classification 1.1 AIIA alone is an oral non-peptide drug, including losartan, valsartan, can-